| Alkermes (NASDAQ:ALKS) is now covered by JPMorgan Chase & Co.. They set a "neutral" rating and a $60.00 price target on the stock. This represents a 15.7% upside from the current price of $51.87. |
| Apyx Medical (NASDAQ:APYX) is now covered by HC Wainwright. They set a "buy" rating and a $7.00 price target on the stock. This represents a 64.3% upside from the current price of $4.26. |
| BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by JPMorgan Chase & Co.. They set a "neutral" rating and a $12.00 price target on the stock. This represents a 21.1% upside from the current price of $9.91. |
| Candel Therapeutics (NASDAQ:CADL) is now covered by Stifel Nicolaus. They set a "buy" rating and a $22.00 price target on the stock. This represents a 128.2% upside from the current price of $9.64. |
| Capstone Energy+ (NASDAQ:CEPL) is now covered by BWS Financial. They set a "buy" rating and a $20.00 price target on the stock. This represents a 94.2% upside from the current price of $10.30. |
| Denali Therapeutics (NASDAQ:DNLI) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $29.00 price target on the stock. This represents a 9.5% upside from the current price of $26.48. |
| First Carolina Financial Services (NYSE:FCBM) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $15.00 price target on the stock. This represents a 17.7% upside from the current price of $12.74. |
| Glass House Brands (NYSE:GLAS) is now covered by Lake Street Capital. They set a "buy" rating and a $17.00 price target on the stock. This represents a 48.5% upside from the current price of $11.45. |
| Honeywell Aerospace (NASDAQ:HONA) is now covered by Evercore Inc. They set an "in-line" rating and a $250.00 price target on the stock. This represents a 17.3% upside from the current price of $213.05. |
| Kardigan (NASDAQ:KARD) is now covered by Leerink Partners. They set an "outperform" rating and a $37.00 price target on the stock. This represents a 57.2% upside from the current price of $23.53. |
| Kardigan (NASDAQ:KARD) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $51.00 price target on the stock. This represents a 116.7% upside from the current price of $23.53. |
| Legend Biotech (NASDAQ:LEGN) is now covered by JPMorgan Chase & Co.. They set a "neutral" rating and a $35.00 price target on the stock. This represents a 35.9% upside from the current price of $25.75. |
| Liftoff Mobile (NASDAQ:LFTO) is now covered by Tigress Financial. They set a "buy" rating and a $39.00 price target on the stock. This represents a 62.7% upside from the current price of $23.97. |
| NervGen Pharma (NASDAQ:NGEN) is now covered by Leerink Partners. They set an "outperform" rating and a $10.00 price target on the stock. This represents a 418.1% upside from the current price of $1.93. |
| NLS Pharmaceutics (NASDAQ:NCEL) is now covered by Laidlaw. They set a "buy" rating and a $23.00 price target on the stock. This represents a 475.0% upside from the current price of $4.00. |
| NovoCure (NASDAQ:NVCR) is now covered by JPMorgan Chase & Co.. They set a "neutral" rating and a $17.00 price target on the stock. This represents a 5.7% upside from the current price of $16.09. |
| Park Aerospace (NYSE:PKE) is now covered by Needham & Company LLC. They set a "buy" rating and a $43.00 price target on the stock. This represents a 28.7% upside from the current price of $33.40. |
| Spruce Biosciences (NASDAQ:SPRB) is now covered by B. Riley Financial, Inc.. They set a "buy" rating and a $160.00 price target on the stock. This represents a 230.7% upside from the current price of $48.38. |
| Walt Disney (NYSE:DIS) is now covered by Benchmark Co.. They set a "buy" rating and a $115.00 price target on the stock. This represents a 19.9% upside from the current price of $95.91. |
| VivoPower PLC Ordinary Shares (NASDAQ:VIVO) is now covered by Noble Financial. They set an "outperform" rating and a $10.00 price target on the stock. This represents a 119.8% upside from the current price of $4.55. |
| West Pharmaceutical Services (NYSE:WST) is now covered by BNP Paribas Exane. They set an "outperform" rating and a $447.00 price target on the stock. This represents a 24.3% upside from the current price of $359.68. |
| Whirlpool (NYSE:WHR) is now covered by BNP Paribas Exane. They set a "neutral" rating and a $43.00 price target on the stock. This represents a 10.8% upside from the current price of $38.82. |
| Whitehawk Therapeutics (NASDAQ:WHWK) is now covered by Leerink Partners. They set an "outperform" rating and a $9.00 price target on the stock. This represents a 134.4% upside from the current price of $3.84. |
| York Space Systems (NYSE:YSS) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $32.00 price target on the stock. This represents a 66.6% upside from the current price of $19.20. |